Figure 2.
Comparison of driver and CH-related mutations between BMPC and ctDNA. (A) Frequency of mutations detected by combined BMPC-seq and ctDNA-seq analyses in RRMM cases (n = 161). Thirty-six genes detected in ≥3 cases are visualized. Reported CH-related genes are shown in blue. (B) Proportion of cases harboring mutations that are BMPC specific (red), ctDNA specific (blue), and detected by both (yellow). Cases with different BMPC-specific and ctDNA-specific mutations were counted as ctDNA-seq–specific. Thirty-six genes detected in ≥3 cases are visualized. (C) Diagonal plots showing mutant allele frequency in BMPC and ctDNA in representative cases. Mutations with a depth of ≥50× in both BMPC-seq and ctDNA-seq are shown; ND, not detected. (D) Comparison of mutant allele frequency between BMPC and ctDNA. An offset of 0.001 was added to each allele frequency before calculating log2 ratio. Genes with mutation frequency of ≥5% in panel A and/or ctDNA-specific frequency of ≥0.7 in panel B are shown. Other CH consists of ASXL1, SF3B1, and EP300. Two-sided Brunner-Munzel test. (E) Number of mutations for each gene in each case detected by ctDNA-seq (n = 261). Two-sided Fisher exact test.

Comparison of driver and CH-related mutations between BMPC and ctDNA. (A) Frequency of mutations detected by combined BMPC-seq and ctDNA-seq analyses in RRMM cases (n = 161). Thirty-six genes detected in ≥3 cases are visualized. Reported CH-related genes are shown in blue. (B) Proportion of cases harboring mutations that are BMPC specific (red), ctDNA specific (blue), and detected by both (yellow). Cases with different BMPC-specific and ctDNA-specific mutations were counted as ctDNA-seq–specific. Thirty-six genes detected in ≥3 cases are visualized. (C) Diagonal plots showing mutant allele frequency in BMPC and ctDNA in representative cases. Mutations with a depth of ≥50× in both BMPC-seq and ctDNA-seq are shown; ND, not detected. (D) Comparison of mutant allele frequency between BMPC and ctDNA. An offset of 0.001 was added to each allele frequency before calculating log2 ratio. Genes with mutation frequency of ≥5% in panel A and/or ctDNA-specific frequency of ≥0.7 in panel B are shown. Other CH consists of ASXL1, SF3B1, and EP300. Two-sided Brunner-Munzel test. (E) Number of mutations for each gene in each case detected by ctDNA-seq (n = 261). Two-sided Fisher exact test.

Close Modal

or Create an Account

Close Modal
Close Modal